9th Annual World ADC in Review

Mon, Nov 26th 2018
Karen Cha, Halloran's new Vice President, Early Development, recently led a workshop at the 9th Annual ADC World Congress, held in San Diego, CA. 
Read More

NIH RAC Changes

Tue, Aug 21st 2018

The changes to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee (RAC) protocol review and reporting structure, which were reflected in changes to the Federal Register on August 17th, 2018, will affect gene and cell therapy Sponsors in these three significant ways.

Read More

How to prevent clinical trial protocol deviations

When protocols are not followed, it can create serious issues that slow the study down or significantly increase costs.  These best practices can help sponsors and CROs work together seamlessly to prevent and alleviate protocol deviations in their clinical studies keeping development on time and within budget.
Read More